Department of Urology at Cedars-Sinai
@CS_Urology
Followers
2K
Following
951
Media
163
Statuses
636
Official account for the Cedars-Sinai Department of Urology including all academic faculty and trainees.
8700 Beverly Blvd. Los Angele
Joined July 2019
👏Congrats to our graduating chiefs!. @PerisCast ➡️Recon fellowship @LaheyUro .@JeremiahDallmer ➡️Andrology fellowship @IUuro . 👨🏫& congrats @MichaelAhdootMD for the faculty teaching award
1
7
25
👏 well-earned @MichaelAhdootMD !.
These crazy guys gave me a teaching award when really the night was all about them. Dr @PerisCast and Dr Jeremiah Dallmer, congratulations on completing residency and moving on to your fellowships. You are two amazingly attended young surgeons.
1
0
4
RT @jgong15: Join us for this joint @AmericanCancer @LACareHealth free #CME webinar on #prostatecancer screening . Thursday, July 17, 2025….
0
7
0
🚨Job posting for Endourology!!🚨. @CedarsSinai . 🪨We are looking for a stone expert to join our faculty. 🌎World class research & facilities . 😁 Dedicated team of OR & clinic staff. 👋Motivated & hardworking residents. 👇Find out more in the link. 🔗
0
5
10
😎 check out prof @SFreedlandMD on @urotoday.
#EMBARK analysis: Testosterone recovery post-ADT in high-risk #ProstateCancer patients. @SFreedlandMD @CedarsSinai joins @zklaassen_md @GACancerCenter in this discussion on UroToday/ #WatchNow >
2
0
5
🚨Oncuria-Detect🚨. 🔬Prof Charles J. Rosser, MD . 💧Urine-based test . 💡Negative predictive value 95% for detecting bladder cancer among pts w/ hematuria🩸regardless of stage/grade. 📉 Could reduce the need for 66% of cystoscopies . Open access🔗
0
6
11
🚨Not all biochemical recurrences are =🚨. 👉Associate Prof @TimDaskivich & Prof @SFreedlandMD show #prostatecancer progression differs among pts w/ BCR treated w/ hormone therapy. ✍️@JUrology . 🔗 @JohnMastersonMD @UCSFUrology @UclaUrology
1
12
28
🚨It's a match🚨.PGY4 @john_r_heard matched @UroOnc w/ @WCMUrology !!!!. 👏We're so proud of you!. @jimhumd @Chris_Barbieri1 @RodriguezMDUrol
1
9
42
🚨Shared-decision making (SDM) for #prostatecancer🚨. ☝️Guidelines support SDM when it comes to choosing treatment . 💡Associate prof @TimDaskivich analyzed 50 convos between MDs & patients to standardize SDM. @urogoldjournal . 🔗
1
3
15
👏Congratulations Prof @doldivizio on your publication in @CellRepMed on large oncosomes in multiple cancers with a deep dive in #prostatecancer. 🔗 @Boutroslab @EdwinPosadasMD @CSCancerCenter @PCFnews.
🎉 Excited to share our new publication in Cell Reports Medicine! 🙌.Big thanks to our amazing collaborators!. 📄 #LiquidBiopsy #Oncosomes #EVresearch #RNASeq #CancerBiology #CellReportsMedicine
0
3
7
Associate prof @TimDaskivich discussed his recent publication in @JAMAInternalMed w/ @urotoday 👇. @CSCancerCenter @CedarsSinaiMed @CedarsSinai.
Overtreatment of #ProstateCancer persists in men with limited life expectancy. @TimDaskivich @CedarsSinai and @zklaassen_md @GACancerCenter discuss this @JAMAInternalMed publication and the findings from a study of 243,000 VA patients that reveals increasing rates of definitive
0
6
12
RT @SFreedlandMD: Nice analysis from IRONMAN matching our VA results presented yesterday: in mHSPC - if the PSA is not <0.2 that is bad. Le….
0
3
0
RT @SFreedlandMD: Phase 3 of novel viral vector in #prostatecancer pts getting XRT. Intermediate to high-risk. Despite slide title - only h….
0
11
0
RT @SFreedlandMD: Updated results from #ARCHES in mHSPC showing sustained benefits of #enzalutamide with minimum 5 year followup. 3 year su….
0
10
0
RT @SFreedlandMD: Excited to present new data from #EMBARK showing that in high risk BCR #prostatecancer patients that #enzalutamide alone….
0
6
0
RT @SFreedlandMD: Important real world data that even if PSA drops 90% in mHSPC - that is not good enough unless PSA is <0.2. Let’s set the….
0
7
0
RT @SFreedlandMD: No clear benefit to adding docetaxel to long term ADT for high-risk or very high-risk #prostatecancer patients getting #r….
0
9
0
RT @jgong15: @tompowles1 #ctDNA of periop durva + NAC in #MIBC (Ph III NIAGARA) ➡️ @NateraGenetics ctDNA baseline and clearance prognostic….
0
7
0
RT @jgong15: @ANZUPtrials rand PhIII ANZUP 1301 of intravesical MMC + BCG vs BCG in tx-naive #HR-NMIBC ➡️ no sig diff in DFS, time to recur….
0
8
0
RT @jgong15: Dr. Dhanawat rand PhIII non-inferiority trial of adj platinum/5-FU vs platinum/paclitaxel after resected #penilecancer ➡️ due….
0
9
0